Using advanced imaging to study retinal disorders
Official title: Adaptive Optics Imaging in Retinal Disorders
Run by The Hospital for Sick Children · NCT05386134 · Data updated 2026-11-12
This study is testing a new imaging technology to see how it can help understand and track changes in the eyes of people with inherited and acquired retinal disorders.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 5 Years to 70 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | The Hospital for Sick Children Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Status | Recruiting |
| Started | June 13, 2022 |
| Main results expected | June 13, 2032 |
| Study ends | June 13, 2033 |
| Registry record updated | April 28, 2026 |
| Trial ID | NCT05386134 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals aged 5 to 70 years diagnosed with well-documented inherited or acquired retinal diseases.
✕Probably not a fit
Patients with significant eye movement disorders or other conditions that prevent stable imaging may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to explore the underlying retinal abnormalities in patients with inherited and acquired retinal disorders using adaptive optics (AO) technology. Approximately 200 participants, including a control group, will be recruited to undergo detailed retinal imaging and assessments. The study will track changes in retinal structures before and after various treatments, helping to establish AO imaging as a potential outcome measure for these conditions. Participants will have follow-up visits at 6 months and 1 year to monitor their progress.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of retinal disorders and improve treatment outcomes through better monitoring of retinal changes.
How similar studies have gone: Other studies utilizing adaptive optics imaging have shown promise in understanding retinal diseases, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Consent provided 2. Aged 5 - 70 years 3. Diagnosed with well documented retinal disorder Control group Inclusion Criteria: 1. Subjects aged 5 years - 70 years with normal eye examination. 2. Patients with strabismus and otherwise normal visual acuity and eye examination 3. Patients with unilateral eye diseases such as cataract, with a normal eye exam in the fellow eye. Exclusion Criteria: 1. Inability of the subject to maintain a stable position while seated 2. Uncontrolled nystagmus, trembling or movements of the eyes or the head 3. Presence of cataract or any opacity in the front of the eye that obscures retinal imaging 4. Any general disease such neurological disease which could affect vision and the retina. 5. History of previous uveitis, glaucoma, previous intra-ocular surgery or photodynamic therapy 6. High refractive errors (\> +15D or \< -15D) that cannot be corrected by the adaptive optics system. 7. Patients who have a history of photosensitivity or take any medicine that cause photosensitivity as a side effect 8. Patients who are aphakic after cataract surgery
Where it's running
-
The Hospital for Sick Children
Toronto, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Ajoy Vincent, MS — Associate Professor
- Study coordinator: Ajoy Vincent, MS
- Email: ajoy.vincent@sickkids.ca
- Phone: 416-813-1500
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Newborn whole-genome sequencing and genetic disease risk in pregnancy and early life
This project will collect small biological samples from pregnant families and newborns to try whole-genome sequencing and other multi-omics tests to find genetic disease risks.
-
Multicenter study of SHANK3-related Phelan-McDermid syndrome genetic modifiers
Researchers are testing how other genes may modify the PMS clinical picture in people with SHANK3-related deletions or variants.
-
Prenatal cfDNA Screening in Pregnancies with Diverse Genetic Risk Profiles
This study tests two cfDNA approaches from a single maternal blood sample to see if they can detect a wide range of fetal genetic conditions in pregnant people with various risk factors.
-
Natural history of type I interferonopathies in a European patient group
This project will follow people with genetically confirmed type I interferonopathies across European centers to see how the disease develops and which clinical and blood markers track disease activity.
-
Speech-generating device to help communication in childhood dementia
This project will test whether giving children with childhood dementia a speech-generating iPad app helps them communicate better than their usual care.
-
Using AI to enhance cardiology patient care
This study is testing if using AI tools can help cardiologists make better decisions when treating patients with heart conditions compared to traditional methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.